Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Organovo Holdings ( (ONVO) ) has issued an announcement.
Organovo Holdings, Inc. appointed Norman Staskey as the new President, Chief Financial Officer, and Principal Financial Officer following the resignation of Tomas Hess, who left to pursue retirement. Mr. Staskey, with a strong background in mergers, acquisitions, and financial management, will continue providing his services through a consulting agreement with Danforth Advisors, indicating Organovo’s ongoing strategic initiatives in the pharmaceutical sector.
More about Organovo Holdings
Organovo Holdings, Inc. operates in the life sciences industry and focuses on strategic transactions with other pharmaceutical companies. The company provides financial consulting services and employs internal finance staff to ensure operational continuity.
YTD Price Performance: -67.66%
Average Trading Volume: 157,614
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $5.52M
Find detailed analytics on ONVO stock on TipRanks’ Stock Analysis page.
